Table 2.
No | Circ | Host gene | Vitro Functions | Specimen | Expression | Reference | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Prolife | Cycle | Apopt | Migra | Invas | Angio | Other | ||||||
1 | ciRS7 | CDR1as | + | + | BXPC3/PANC1 | Up | 30,898,507 | |||||
2 | 0000284 | HIPK3 | + | BXPC3 | Up | 29,255,366 | ||||||
3 | 0005273 | PTK2 | + | + | ASPC1/CFPAC1 | Up | 33,275,224 | |||||
4 | chr12:7,467,880,474,700,449 | + | BXPC3 | Up | 32,879,441 | |||||||
5 | 0001649 | SHPRH | + | + | BXPC3/PANC1 | Down | 29,969,694 | |||||
6 | ASH2L | ASH2L | + | + | + | + | + | CAPAN1/ASPC1 | Up | 31,718,694 | ||
7 | 0001460 | NEIL3 | + | + | + | + | CFPAC1/MIAPACA2 | Up | 33,750,389 | |||
8 | 0013912 | POLR3C | + | + | + | + | + | ASPC1/PANC1 | Up | 32,884,344 | ||
9 | 0050102 | PGPEP1 | + | + | + | + | + | CFPAC1/PANC1 | Up | 33,289,016 | ||
10 | 0000662 | AXIN1 | + | + | + | + | + | ASPC1 | Down | 33,425,718 | ||
11 | 0000677 | ABCC1 | + | + | + | + | ASPC1/BXPC3 | Up | 33,413,045 | |||
12 | 0007534 | DDX42 | + | + | + | PANC1/SW1990 | Up | 30,382,592 | ||||
13 | 0001946 | CDR1as | + | + | + | + | ASPC1/PANC1 | Up | 33,593,338 | |||
14 | 0006215 | SLC4A7 | + | + | + | PANC1 | Up | 29,930,719 | ||||
15 | 0060055 | EIF6 | + | + | + | + | HS766T/SW1990 | Up | 33,469,368 | |||
16 | 0066147 | SFMBT1 | + | + | + | + | BXPC3/PANC1 | Up | 32,855,541 | |||
17 | 0071036 | INPP4B | + | + | + | ASPC1/PANC1 | Up | 33,507,122 | ||||
18 | 0099999 | ZMYM2 | + | + | + | CFPAC1/PANC1 | Up | 30,537,731 | ||||
19 | IARS | IARS | Endothelial permeability | Exo-HUVEC/ASPC1/HS766T/HS766T-L2 | Up | 30,064,461 | ||||||
20 | 0036627 | PDE8A | + | + | + | + | Scatteration | BXPC3/CAPAN2/Exo-HS766T | Up | 29,709,702 | ||
21 | ADAM9 | ADAM9 | + | + | + | CAPAN1/MIAPACA2 | Up | 31,810,373 | ||||
22 | 0000069 | STIL | + | + | + | + | + | MIAPACA2/SW1990; Exo-HPDE/SW1990 | Up | 33,324,055 | ||
23 | 0009065 | BFAR | + | + | + | BXPC3/PANC1 | Up | 32,375,768 | ||||
24 | 0043278 | TADA2A | + | + | + | PANC1/SW1990 | Up | 33,505,218 | ||||
25 | 0075829 | CASC15 | + | + | + | BXPC3/SW1990 | Up | 33,184,989 | ||||
26 | chr7:154,954,255,154,998,784 | + | + | + | PANC1 + NAPSC/CAPSC | Up | 33,042,405 | |||||
27 | LDLRAD3 | LDLRAD3 | + | + | + | PANC1/SW1990 | Up | 31,521,692 | ||||
28 | 0001013 | KIAA1841 | + | + | + | + | ASPC1/PANC1 | Up | 33,563,550 | |||
29 | 0001568 | DUSP22 | + | + | + | + | + | BXPC3/CAPAN2 | Up | 32,193,152 | ||
30 | 0000979 | TCONS_00003590 | + | + | + | + | PANC1 | Down | 32,878,470 | |||
31 | 0086375 | NFIB | + | + | CAPAN2/PANC1 | Down | 32,366,257 | |||||
32 | circ 03955 | + | + | Glycolysis | BXPC3/PANC1 | Up | 33,864,618 | |||||
33 | 0007334 | MBOAT2 | + | + | + | + | Glutamine metabolism | PANC1/SW1990 | Up | 33,832,516 | ||
34 | 0000977 | NOL10 | Inhibition of NK cells under hypoxia | PANC1/NK cell | Induced by hypoxiain | 31,402,756 | ||||||
35 | 0007367 | UBAP2 | Immune infiltration | GSE69362 and GSE79634 | Up | 31,584,877 | ||||||
36 | 0002130 | C3 | PANC1/SW1990; PDX tumor | Up | 32,727,565 | |||||||
37 | 0092314 | RANBP1 | + | + | CSC | ASPC1/PACA2 | Up | 33,842,379 | ||||
38 | 0005397 | RHOT1 | + | + | + | CAPAN2/PANC1 | Up | 30,444,423 | ||||
39 | 0007334 | MBOAT2 | + | PANC1 | 31,428,151 | |||||||
40 | 0030235 | RCBTB2 | + | + | + | + | PANC1/SW1990 | Up | 30,591,218 | |||
41 | 0000816 | FOXK2 | + | + | + | + | + | CFPAC1/PANC1 | Up | 32,217,695 | ||
42 | 0006988 | LDLRAD3 | ASPC1/CAPAN2/HPCY5/HPDE6C7/PANC1/SW1990 | Up | 29,307,994 | |||||||
43 | chr14:101,402,109,101,464,448 | SNHG23 | + | GEM-resistance | PANC1-GEM | Up | 29,922,161 | |||||
44 | chr4:5,272,960,352,780,244 | DCUN1D4 | + | GEM-resistance | PANC1-GEM | Up | 29,922,161 | |||||
45 | 0000284 | HIPK3 | + | + | + | + | GEM-resistance | PANC1/SW1990-GEM | Up | 32,104,074 | ||
46 | 101672/004077/003251 | GEM-resistance | SW1990-GEM | Up | 29,781,033 | |||||||
47 | 101543/002747/000926 | GEM-resistance | SW1990-GEM | Down | 29,781,033 |
Prolife: Proliferation; Cycle: Cell cycle; Apopt: Apoptosis; Migra: Migration; Invas: Invasion; Angio: Angiogenesis; CSC: Cancer Stem Cell; GEM: Gemcitabine